(Q41641521)

6 October 2017

1 reference

title

Pharmacologic prevention of acute ischemic complications of coronary angioplasty (English)

1 reference

6 October 2017

N Wheeldon

1

1 reference

6 October 2017

D Cumberland

series ordinal

2

1 reference

6 October 2017

publication date

1 November 1997

1 reference

Catheterization and cardiovascular diagnosis

6 October 2017

published in

1 reference

6 October 2017

volume

42

1 reference

6 October 2017

issue

3

1 reference

6 October 2017

page(s)

249-256

1 reference

Acute coronary artery occlusion during percutaneous transluminal coronary angioplasty treated by redilation of the occluded segment

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Role of intracoronary thrombus in acute complications during percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Clinical factors affecting the immediate outcome of PTCA in patients with unstable angina and poor candidates for surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Predictors of major ischemic complications after coronary dissection following angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Tear or dissection after coronary angioplasty. Morphologic correlates of an ischemic complication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Thrombolysis as an adjunct to angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Recent changes in the management and outcome of acute closure after percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Multicenter clinical experience with rescue atherectomy for failed angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Coronary angioplasty in patients with unstable angina pectoris: is there a role for thrombolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Intracoronary urokinase for intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty in acute ischemic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Safety and efficacy of urokinase during elective coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Intracoronary urokinase as an adjunct to percutaneous transluminal coronary angioplasty in patients with complex coronary narrowings or angioplasty-induced complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Influence on early outcome and restenosis of urokinase before elective coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Enhancing safety and outcomes with the newer antithrombotic and antiplatelet agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

The occurrence of early sudden coronary artery occlusion following angioplasty may be predicted from the clinical characteristics of the patients and their coronary lesion morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Predicting the risk of abrupt vessel closure after angioplasty in an individual patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Continuous coronary flow velocity monitoring during coronary interventions: velocity trend patterns associated with adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Continuous coronary perfusion balloon catheters in coronary dissections after percutaneous transluminal coronary angioplasty. Acute clinical results and 6-months follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Coronary stenting for acute coronary dissection after coronary angioplasty: implications of residual dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Effect on early acute occlusion rate of adjunctive antithrombotic treatment with intravenously administered dipyridamole during percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Subcutaneous heparin in postangioplasty management: comparative trial with intravenous heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results of the TAUSA Trial. TAUSA Investigators. Thrombolysis and Angioplasty in Unstable Angina trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: the Dispatch catheter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Atrial natriuretic peptide release responds to atrial stretch and not to atrial pressure: observations during pericardiocentesis in a young woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

The interaction of platelet factor four and glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

Comparative safety profiles of hirulog and heparin in patients undergoing coronary angioplasty. The Hirulog Angioplasty Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0304%28199711%2942%3A3%3C249%3A%3AAID-CCD2%3E3.0.CO%3B2-C

10.1002/(SICI)1097-0304(199711)42:3<249::AID-CCD2>3.0.CO;2-C

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference